Referências
1. Sociedade Brasileira de Pneumologia e Tisiologia.
2. Cançado JED, Penha M, Gupta S, Li VW, Julian GS, Moreira ES. Respira project: Humanistic and
economic burden of asthma in Brazil. J Asthma. 2019;56(3):244-251. https://doi.org/10.1080/0277
0903.2018.1445267.
3. Adeloye D, Song P, Zhu Y, Campbell H, Sheikh A, Rudan I; NIHR RESPIRE Global Respiratory
Health Unit. Global, regional, and national prevalence of, and risk factors for, chronic
obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet
Respir Med. 2022 May;
4. Foo J et al. Continuing to Confront COPD International Patient Survey: Economic Impact of
COPD in 12 Countries. PLoS One. 2016 Apr 19;11(4)
5. Kunisaki KM, et al. Exacerbations of chronic obstructive pulmonary disease and cardiac events
a post hoc cohort analysis from the SUMMIT randomized clinical trial. Am J Respir Crit Care Med.
2018
BR-38054 | Material destinado a profissionais de saúde | Abril/2025